4 Largecap High Quarterly Margin and Low Debt Stocks to Watch for Future Multibagger Potential: TCS, Sun Pharma, Pidilite and Indian Hotels

High quarterly margin and low debt stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. TCS, Sun Pharma, Pidilite and Indian Hotels meet that test, with market caps from Rs 1.12 lakh crore to Rs 8.31 lakh crore and TCS offering the highest return on equity at 43.37%. Each of these companies has a latest quarter operating margin of at least 20 per cent and a debt to equity ratio below 0.3, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a latest quarter operating margin of at least 20 per cent and a debt to equity ratio below 0.3, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening high quarterly margin and low debt stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 30 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are High Quarterly Margin and Low Debt Stocks and Why Do They Attract Multibagger Interest?

High quarterly margin and low debt stocks are shares of large companies that kept at least twenty paise of operating profit from every rupee of sales in the latest quarter and carry very little debt, so a rich current margin sits on a clean balance sheet. The four here cover IT services, pharmaceuticals, adhesives and hotels.

A high margin in the latest quarter shows that pricing power and cost control are working now, and low debt means that the extra profit is not eaten up by interest. For high quarterly margin and low debt stocks, both FY26 and the latest quarter showed growth. Whichever way you read high quarterly margin and low debt stocks, the common thread is rising profit backed by complete financial data. With high quarterly margin and low debt stocks, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for high quarterly margin and low debt stocks are complete. Read each company’s latest results and exchange filings before acting on high quarterly margin and low debt stocks.

High Quarterly Margin and Low Debt Stocks at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 30 October 2026. TCS combines the lowest PE of the group, 16.03, with the highest return on equity, 43.37%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Debt to Equity	52-Week Range (Rs)
Tata Consultancy Services	2,502.60	8,31,455	16.03	18.27	43.37%	0.10	1,976.80 to 3,350.00
Sun Pharmaceutical Industries	1,777.70	4,27,161	35.25	36.42	13.74%	0.06	1,583.70 to 2,046.90
Pidilite Industries	1,461.60	1,51,179	56.50	36.15	22.61%	0.04	1,259.00 to 1,707.50
Indian Hotels Company	811.65	1,12,493	48.72	36.77	15.97%	0.22	568.70 to 971.00

TCS: Return on Equity of 43.37%

TCS is India’s largest IT services company by market capitalisation and runs large AI and data practices for global clients. It reported FY26 revenue of Rs 2,71,423 crore, up 4.68% year on year, and net profit of Rs 49,454 crore, up 1.35%. Net profit has compounded at 6.49% a year since FY22, while revenue has grown 8.51% a year. Operating margin was 27.07% in FY26. The debt-to-equity ratio is 0.10, which keeps interest costs low.

In the September 2026 quarter, revenue rose 11.79% to Rs 74,525 crore and net profit grew 14.86% to Rs 13,934 crore. Domestic institutions raised their holding from 12.01% in June 2025 to 13.47% in June 2026. The stock trades at a PE of 16.03 against an industry PE of 18.27, below the sector average, with a return on equity of 43.37%. The dividend yield is 4.79%.

Sun Pharma: 35.75% Profit CAGR Since FY22

Sun Pharmaceutical Industries is one of India’s largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.

The stock trades at a PE of 35.25 against an industry PE of 36.42, below the sector average, with a return on equity of 13.74%. In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 110.81% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026.

Pidilite: Return on Equity of 22.61%

Pidilite Industries makes Fevicol, Dr. Fixit and other adhesives and construction chemicals. It reported FY26 revenue of Rs 14,867.01 crore, up 11.05% year on year, and net profit of Rs 2,470.72 crore, up 17.87%. Net profit has compounded at 19.62% a year since FY22, while revenue has grown 10.54% a year. Operating margin was 25.81% in FY26. The debt-to-equity ratio is 0.04, which keeps interest costs low.

In the June 2026 quarter, revenue rose 20.96% to Rs 4,643.55 crore and net profit grew 30.29% to Rs 883.51 crore. Domestic institutions raised their holding from 9.15% in June 2025 to 9.88% in June 2026. The stock trades at a PE of 56.50 against an industry PE of 36.15, with a return on equity of 22.61%.

Indian Hotels: Quarterly Profit Up 22.39%

Indian Hotels Company, part of the Tata Group, runs Taj, SeleQtions, Vivanta and Ginger hotels and resorts. It reported FY26 revenue of Rs 9,971.43 crore, up 16.42% year on year, and net profit of Rs 2,195.14 crore, up 11.93%. Revenue has compounded at 32.74% a year since FY22. Operating margin was 35.53% in FY26. The debt-to-equity ratio is 0.22.

The stock trades at a PE of 48.72 against an industry PE of 36.77, with a return on equity of 15.97%. In the June 2026 quarter, revenue rose 15.09% to Rs 2,419.37 crore and net profit grew 22.39% to Rs 390.93 crore. The share price has gained 658.38% over five years. Domestic institutions raised their holding from 18.52% in June 2025 to 24.59% in June 2026.

High Quarterly Margin and Low Debt Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these high quarterly margin and low debt stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	Latest Quarter Revenue Growth	Operating Margin (Latest Quarter)
TCS	2,71,423	49,454	4.68%	8.51%	11.79%	27.53%
Sun Pharma	61,673.94	11,564.52	12.69%	11.62%	11.93%	32.52%
Pidilite	14,867.01	2,470.72	11.05%	10.54%	20.96%	28.62%
Indian Hotels	9,971.43	2,195.14	16.42%	32.74%	15.09%	32.19%

Check the Univest Screener for live data on these high quarterly margin and low debt stocks

Institutional Holding in TCS, Sun Pharma, Pidilite and Indian Hotels

Institutional holding shows who is backing these high quarterly margin and low debt stocks alongside the promoter. The table uses the latest reported quarter for each. Indian Hotels has the deepest institutional backing, with FII and DII together holding 46.30% as of June 2026. Domestic institutions increased their holding over the past year in TCS (from 12.01% to 13.47%), Sun Pharma (from 20.23% to 22.27%), Pidilite (from 9.15% to 9.88%) and Indian Hotels (from 18.52% to 24.59%).

Stock	Promoter	FII	DII	Public	Quarter
TCS	71.77%	9.06%	13.47%	5.70%	June 2026
Sun Pharma	52.68%	14.36%	22.27%	10.70%	September 2026
Pidilite	69.24%	11.69%	9.88%	9.18%	June 2026
Indian Hotels	38.12%	21.71%	24.59%	15.58%	June 2026

Risks to Weigh in High Quarterly Margin and Low Debt Stocks

Being careful with high quarterly margin and low debt stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Pidilite trades at a PE of 56.50 against an industry PE of 36.15, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between High Quarterly Margin and Low Debt Stocks

Picking from high quarterly margin and low debt stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (18.27 to 36.77) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track TCS, Sun Pharma, Pidilite and Indian Hotels live prices.

Conclusion

Among high quarterly margin and low debt stocks, TCS stands out for the highest return on equity at 43.37%, Sun Pharma for the fastest profit growth, 35.75% a year since FY22, Pidilite for the strongest latest-quarter profit growth at 30.29% and Indian Hotels for the biggest five-year price gain at 658.38%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing high quarterly margin and low debt stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on High Quarterly Margin and Low Debt Stocks to Watch

Which are the best high quarterly margin and low debt stocks to watch for multibagger potential?

Ans. TCS, Sun Pharma, Pidilite and Indian Hotels are the 4 names this list highlights, with market caps of Rs 8,31,455 crore, Rs 4,27,161 crore, Rs 1,51,179 crore and Rs 1,12,493 crore respectively. TCS is notable for the highest return on equity at 43.37%. Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22. Pidilite offers the strongest latest-quarter profit growth at 30.29%. Indian Hotels brings the biggest five-year price gain at 658.38%. These are watchlist names for high quarterly margin and low debt stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is TCS a good stock for long-term investors?

Ans. TCS has a return on equity of 43.37%, a PE of 16.03 against an industry PE of 18.27 and a market cap of Rs 8,31,455 crore. Net profit has compounded at 6.49% a year since FY22, and FY26 revenue rose 4.68% while September 2026 quarter net profit grew 14.86%. Long-term returns in high quarterly margin and low debt stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Sun Pharma become a multibagger from here?

Ans. Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in high quarterly margin and low debt stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 35.25 against an industry PE of 36.42, valuation should be checked against that growth before investing.

What is the market cap of TCS, Sun Pharma, Pidilite and Indian Hotels?

Ans. As of 30 October 2026, TCS has a market cap of Rs 8,31,455 crore, Sun Pharma has a market cap of Rs 4,27,161 crore, Pidilite has a market cap of Rs 1,51,179 crore and Indian Hotels has a market cap of Rs 1,12,493 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on high quarterly margin and low debt stocks.

What are the risks of investing in high quarterly margin and low debt stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Pidilite trades at a PE of 56.50 against an industry PE of 36.15, so earnings growth needs to hold up.

Why is Pidilite trading at a PE of 56.50?

Ans. Pidilite’s PE of 56.50 compares with an industry PE of 36.15. The market is paying a premium for a return on equity of 22.61%, profit growth of 19.62% a year since FY22 and latest-quarter profit growth of 30.29%, which also means the stock is more sensitive if growth slows. Investors in high quarterly margin and low debt stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in TCS, Sun Pharma, Pidilite and Indian Hotels?

Ans. As of the latest reported quarter, FII and DII together hold 22.53% of TCS (9.06% and 13.47%), 36.63% of Sun Pharma (14.36% and 22.27%), 21.57% of Pidilite (11.69% and 9.88%) and 46.30% of Indian Hotels (21.71% and 24.59%). Rising institutional holding is a useful signal in high quarterly margin and low debt stocks, though it should be read with earnings trends rather than on its own.